Intra-operative mitomycin C for nonpenetrating filtering surgery in treatment of open angle glaucoma: a systematic review and meta-analysis
SHEN Ya,GAO Lian-di,CHENG Jin-wei,CAI Ji-ping,LI You,WEI Rui-li
DOI: https://doi.org/10.3724/SP.J.1008.2012.01006
2012-01-01
Academic Journal of Second Military Medical University
Abstract:Objective To compare the efficacy and tolerability between nonpenetrating filtering surgery with(NPFS-MMC) and without(NPFS-noMMC) intraoperative mitomycin C application for treatment open angle glaucoma.Methods Pertinent studies were selected through extensive searches of the Cochrane Library,PubMed,Embase,and Chinese Biomedicine Database.Eight controlled clinical trials meeting the pre-defined criteria were systematically reviewed by meta-analysis.The main outcome measures were percentage intraocular pressure reduction(IOPR%),complete remission rate,total remission rate,and complications.The pooled estimates were carried out using RevMan version 5.0 software.Results The weighted mean differences of the IOPR% between the NPFS-MMC group and NPFS-noMMC group were 5.24%(95% confidence intervals,-3.24 to 13.72) after 6 months,8.31%(95%CI,4.33 to 12.30) after 12 months(P<0.05),9.56%(95%CI,4.88 to 14.24) after 24 months(P<0.05),and 14.45%(95%CI,9.02 to 19.88) after 36 months(P<0.05).NPFS-MMC was associated with significant greater complete remission rates compared with NPFS-noMMC,with the pooled risk difference being 1.16(95%CI,1.05 to 1.27) after 6 months(P<0.05),1.20(95%CI,1.05 to 1.38) after 12 months(P<0.05),1.30(95%CI,1.05 to 1.61) after 24 months(P<0.05),and 1.36(95%CI,1.06 to 1.73) after 36 months(P<0.05).Intraoperative mitomycin C was not associated with any drug-induced complications.Conclusion The use of intraoperative mitomycin C is safe and can improve the effect of nonpenetrating filtering surgery in patients with open ganle glaucoma.